postoperative nausea- vomiting and pain following laparoscopic uterine surgery
Conditions
Interventions
Anrikefon group:Anrikefon Injection
Sufentanil group:Sufentanil injection
Sponsors
The First People's Hospital of Foshan
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Sign a dated informed consent form voluntarily; 2. Females aged 18 to 65 years old; 3. Patients scheduled for laparoscopic uterine surgery; 4. American Society of Anesthesiologists (ASA) Physical Status I to III; 5. Patient-controlled intravenous analgesia should be applied after the operation.
Exclusion criteria
Exclusion criteria: 1. Emergency surgery; 2. BMI >= 35 kg/m^2; 3. Allergic to drugs used in this study; 4. Preoperative coexistence of severe cardiovascular or cerebrovascular diseases; 5. Preoperative coexistence of severe respiratory system diseases; 6. Preoperative coexistence of severe liver disease; 7. Patients with preoperative renal dysfunction (serum creatinine exceeding 176 µmol/L); 8. Alcohol addiction history; 9. Long-term use of opioids or other analgesic; 10. Due to various reasons, they were unable to understand the application of PCIA or were unable to cooperate with the pain rating personnel.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the incidence of postoperative nausea and vomiting within 24h from the end of the surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| The NRS score for pain during 48 hours after the operation; | — |
Countries
China
Contacts
Public ContactHanbing Wang
The First People's Hospital of Foshan
Outcome results
None listed